Clinical and Immunological Features of the Study Groups
Characteristic . | Controls (n = 20) . | C-KS (n = 18) . | AIDS-KS (n = 22) . |
---|---|---|---|
Sex (M/F) | 15/5 | 18/0 | 21/1 |
Age (mean yr ± SD) | 40 ± 10 | 60 ± 8 | 30 ± 10 |
Risk factor for HIV-1 infection | None | None | 18 Homo 4 hetero |
CD3+ cells/μL | 1,310 ± 380 | 1,380 ± 298 | 1,298 ± 220 |
CD16+ cells/μL | 264 ± 12 | 268 ± 12 | 271 ± 20 |
CD4+ cells/μL | 780 ± 104 | 750 ± 106 | 325 ± 206 |
CD8+ cells/μL | 319 ± 140 | 324 ± 111 | 750 ± 179 |
Characteristic . | Controls (n = 20) . | C-KS (n = 18) . | AIDS-KS (n = 22) . |
---|---|---|---|
Sex (M/F) | 15/5 | 18/0 | 21/1 |
Age (mean yr ± SD) | 40 ± 10 | 60 ± 8 | 30 ± 10 |
Risk factor for HIV-1 infection | None | None | 18 Homo 4 hetero |
CD3+ cells/μL | 1,310 ± 380 | 1,380 ± 298 | 1,298 ± 220 |
CD16+ cells/μL | 264 ± 12 | 268 ± 12 | 271 ± 20 |
CD4+ cells/μL | 780 ± 104 | 750 ± 106 | 325 ± 206 |
CD8+ cells/μL | 319 ± 140 | 324 ± 111 | 750 ± 179 |
The immunologic profile shows similar values of lymphocyte subpopulations in C-KS patients in comparison to normal donors, whereas AIDS-KS patients show abnormalities (see text for statistical analysis). Results are given as the mean (M) ± standard deviations (SD).
Abbreviations: n, number; yr, years of age.